Or, at least, portions of it -- related to the Remicade/Simponi arbitration pending with Schering-Plough; any observations on the recent J&J v. Abbott Remicade $1.67 Billion patent verdict in Texas; and any news on the Abbott v. J&J Simponi patent litigation now pending in Massachusetts. It will all live-stream right here, tomorrow morning, from this link:
. . . .Johnson & Johnson will host a conference call for financial analysts at 8:30 a.m. (Eastern Time) on Tuesday, July 14, 2009, to review second-quarter results. Dominic Caruso, Vice President, Finance and Chief Financial Officer, and Louise Mehrotra, Vice President, Investor Relations, will host the call. . . .
In answer to the very-first question asked on the call, Dominic Caruso, Vice President, Finance and Chief Financial Officer took a "no comment" on the arbitration's outlook, other than to say that J&J has filed for arbitration, and it is awaiting the beginning of it. . . .
No comments:
Post a Comment